scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Peter Liston | |
Robert G Korneluk | |||
Wai Gin Fong | |||
P2860 | cites work | The Hallmarks of Cancer | Q221226 |
Control of apoptosis and mitotic spindle checkpoint by survivin | Q22008570 | ||
Expression, purification, and functional analysis of the human serine protease HtrA2 | Q22254360 | ||
Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway | Q24290124 | ||
Livin, a novel inhibitor of apoptosis protein family member | Q24290377 | ||
KIAP, a novel member of the inhibitor of apoptosis protein family | Q24290762 | ||
Structural basis of caspase-7 inhibition by XIAP | Q24290942 | ||
Structural basis for the inhibition of caspase-3 by XIAP | Q24290945 | ||
A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death | Q24291746 | ||
The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif | Q24291797 | ||
HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins | Q24291802 | ||
SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP) | Q24292189 | ||
IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition | Q24292370 | ||
The neuronal apoptosis inhibitory protein is a direct inhibitor of caspases 3 and 7 | Q24292473 | ||
Human testis-specific PGK gene lacks introns and possesses characteristics of a processed gene | Q24298630 | ||
The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy | Q24308680 | ||
Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes | Q24315805 | ||
X-linked IAP is a direct inhibitor of cell-death proteases | Q24318710 | ||
The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex | Q24323338 | ||
Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors | Q24600405 | ||
NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP | Q27620280 | ||
NMR structure and mutagenesis of the third Bir domain of the inhibitor of apoptosis protein XIAP | Q27626381 | ||
Structural and biochemical basis of apoptotic activation by Smac/DIABLO | Q27626899 | ||
Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain | Q27629143 | ||
Structural basis of IAP recognition by Smac/DIABLO | Q27629148 | ||
Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition | Q28115131 | ||
Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli | Q28116145 | ||
The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins | Q28117866 | ||
Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins | Q28117928 | ||
Terminal differentiation of human keratinocytes and stratum corneum formation is associated with caspase-14 activation | Q28140594 | ||
Activation of NF-kappa B by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1 | Q28144306 | ||
Proliferation, cell cycle and apoptosis in cancer | Q28189476 | ||
X-linked inhibitor of apoptosis protein (XIAP) inhibits caspase-3 and -7 in distinct modes | Q28189754 | ||
Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction | Q28199278 | ||
An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7 | Q28199789 | ||
Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy | Q28200343 | ||
ILPIP, a novel anti-apoptotic protein that enhances XIAP-mediated activation of JNK1 and protection against apoptosis | Q28202543 | ||
A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis | Q28204205 | ||
NALPs: a novel protein family involved in inflammation | Q28206764 | ||
A single BIR domain of XIAP sufficient for inhibiting caspases | Q28266409 | ||
Structural Basis of Caspase Inhibition by XIAP | Q29011600 | ||
Identification and characterization of a spinal muscular atrophy-determining gene | Q29547495 | ||
Genomic organization of the X-linked inhibitor of apoptosis and identification of a novel testis-specific transcript | Q30733915 | ||
Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines | Q30967010 | ||
Cloning and characterization of the multiple murine homologues of NAIP (neuronal apoptosis inhibitory protein). | Q32044137 | ||
Spinal muscular atrophy: molecular pathophysiology | Q33607244 | ||
The NOD: a signaling module that regulates apoptosis and host defense against pathogens | Q34405567 | ||
Apoptosis: a link between cancer genetics and chemotherapy | Q34520432 | ||
Surviving apoptosis | Q34543770 | ||
Caspase activation is required for T cell proliferation | Q36375598 | ||
Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells | Q36375602 | ||
DIABLO promotes apoptosis by removing MIHA/XIAP from processed caspase 9 | Q36376444 | ||
Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control | Q36580820 | ||
c-IAP1 is cleaved by caspases to produce a proapoptotic C-terminal fragment | Q40838878 | ||
Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria | Q43830912 | ||
Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro | Q44066914 | ||
Regulation of the Apaf-1/caspase-9 apoptosome by caspase-3 and XIAP. | Q46820730 | ||
Attenuation of ischemia-induced cellular and behavioral deficits by X chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus. | Q48188556 | ||
Requirement for caspase activation in monocytic differentiation of myeloid leukemia cells. | Q54663743 | ||
Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins | Q64380181 | ||
The inhibitors of apoptosis (IAPs) and their emerging role in cancer | Q77900361 | ||
Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO | Q78785301 | ||
P433 | issue | 53 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | apoptotic process | Q14599311 |
P304 | page(s) | 8568-8580 | |
P577 | publication date | 2003-11-01 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | The inhibitors of apoptosis: there is more to life than Bcl2. | |
P478 | volume | 22 |
Q53595735 | A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma. |
Q33458323 | A novel protein isoform of the multicopy human NAIP gene derives from intragenic Alu SINE promoters |
Q38972543 | A novel small-molecule activator of procaspase-3 induces apoptosis in cancer cells and reduces tumor growth in human breast, liver and gallbladder cancer xenografts |
Q33855378 | A viral caspase contributes to modified apoptosis for virus transmission |
Q46304710 | ARTS binds to a distinct domain in XIAP-BIR3 and promotes apoptosis by a mechanism that is different from other IAP-antagonists |
Q37944935 | ARTS-based anticancer therapy: taking aim at cancer stem cells |
Q40325416 | Activation of the NF-kappaB pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKKalpha. |
Q45862336 | Adenoviral expression of XIAP antisense RNA induces apoptosis in glioma cells and suppresses the growth of xenografts in nude mice |
Q54636526 | Adipose-derived mesenchymal stem cells protect PC12 cells from glutamate excitotoxicity-induced apoptosis by upregulation of XIAP through PI3-K/Akt activation |
Q31149866 | Amsacta moorei Entomopoxvirus inhibitor of apoptosis suppresses cell death by binding Grim and Hid |
Q33998793 | An antiapoptotic neuroprotective role for neuroglobin |
Q92357161 | An inhibitor of apoptosis protein (EsIAP1) from Chinese mitten crab Eriocheir sinensis regulates apoptosis through inhibiting the activity of EsCaspase-3/7-1 |
Q28564996 | Androgen-dependent apoptosis in male germ cells is regulated through the proto-oncoprotein Cbl |
Q37777758 | Antagonists of IAP proteins as cancer therapeutics |
Q35641603 | Antagonizing XIAP-mediated caspase-3 inhibition. Achilles' heel of cancers? |
Q42046756 | Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat. |
Q37684824 | Anti-apoptotic genes in the survival of monocytic cells during infection |
Q39588369 | Anti-proliferative and pro-apoptotic actions of a novel human and mouse ovarian tumor-associated gene OTAG-12: downregulation, alternative splicing and drug sensitization |
Q36052709 | Apoptosis in cerebral ischemia: executional and regulatory signaling mechanisms |
Q42742476 | Apoptosis in health and disease and modulation of apoptosis for therapy: An overview |
Q35814902 | Apoptosis inhibition or inflammation: the role of NAIP protein expression in Hodgkin and non-Hodgkin lymphomas compared to non-neoplastic lymph node |
Q35207610 | Apoptosis modulation as a promising target for treatment of systemic sclerosis |
Q36226739 | Apoptotic pathways and therapy resistance in human malignancies |
Q40394988 | Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer |
Q35060246 | Autophagy is an immediate macrophage response to Legionella pneumophila |
Q39156125 | Azidothymidine hinders arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells by induction of p21 and attenuation of G2/M arrest |
Q40349474 | Bivalent IAP antagonists, but not monovalent IAP antagonists, inhibit TNF-mediated NF-κB signaling by degrading TRAF2-associated cIAP1 in cancer cells |
Q40137818 | Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodgkin's lymphoma cells |
Q28478265 | Calbindin 2 (CALB2) regulates 5-fluorouracil sensitivity in colorectal cancer by modulating the intrinsic apoptotic pathway |
Q35985520 | Caspases: potential targets for regulating cell death. |
Q36922743 | Cdk2 acts upstream of mitochondrial permeability transition during paclitaxel-induced apoptosis |
Q38663042 | Cell cycle-dependent expression of cIAP2 at G2/M phase contributes to survival during mitotic cell cycle arrest |
Q37471658 | Cell survival and apoptosis-related molecules in cancer cells in effusions: a comprehensive review |
Q37260997 | Chronic crude garlic-feeding modified adult male rat testicular markers: mechanisms of action |
Q36490771 | Combinatorial cancer immunotherapy |
Q64107893 | Combined effects of XAF1 and TRAIL on the apoptosis of lung adenocarcinoma cells |
Q37037815 | Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellin |
Q34712380 | Critical role of a survivin/TGF-β/mTORC1 axis in IGF-I-mediated growth of prostate epithelial cells |
Q36517026 | Cross-linking of cell surface amyloid precursor protein leads to increased β-amyloid peptide production in hippocampal neurons: implications for Alzheimer's disease |
Q36637900 | Current insights into the regulation of programmed cell death by NF-kappaB. |
Q38355344 | Cytokine-mediated induction of anti-apoptotic genes that are linked to nuclear factor kappa-B (NF-kappaB) signalling in human islets and in a mouse beta cell line |
Q28567791 | Decreased apoptosome activity with neuronal differentiation sets the threshold for strict IAP regulation of apoptosis |
Q36588920 | Delivery of intracellular-acting biologics in pro-apoptotic therapies |
Q36380210 | Differential regulation of inhibitors of apoptosis proteins in Alzheimer's disease brains |
Q57663667 | Differentiated macrophages acquire a pro-inflammatory and cell death-resistant phenotype due to increasing XIAP and p38-mediated inhibition of RipK1 |
Q27678027 | Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152) |
Q40375014 | Distinct role of calmodulin and calmodulin-dependent protein kinase-II in lipopolysaccharide and tumor necrosis factor-alpha-mediated suppression of apoptosis and antiapoptotic c-IAP2 gene expression in human monocytic cells |
Q46941102 | Docosahexaenoic acid induces ciap1 mRNA and protects human endothelial cells from stress-induced apoptosis |
Q36118763 | Down-regulation of inhibitor of apoptosis levels provides competence for steroid-triggered cell death |
Q53060503 | Downregulating sCLU enhances the sensitivity of hepatocellular carcinoma cells to gemcitabine by activating the intrinsic apoptosis pathway. |
Q37140816 | Early cellular signaling responses to axonal injury |
Q51997138 | Essential postmitochondrial function of p53 uncovered in DNA damage-induced apoptosis in neurons. |
Q54644145 | Expression of C-IAP1, C-IAP2 and SURVIVIN discriminates different types of lymphoid malignancies. |
Q95725168 | Expression of Inhibitor of Apoptosis Gene Family Members in Bladder Cancer Tissues and the 5637 Tumor Cell Line |
Q38867094 | Expression of apoptosis associated proteins Survivin, Livin and Thrombospondin-1 in Burkitt lymphoma |
Q53294171 | Expression of inhibitor of apoptosis family proteins in human oral squamous cell carcinogenesis |
Q38456931 | Expression of inhibitors of apoptosis family protein in 7,12-dimethylbenz[a]anthracene-induced hamster buccal-pouch squamous-cell carcinogenesis is associated with mutant p53 accumulation and epigenetic changes. |
Q81672682 | Expression profile of survivin in acute leukaemias: the importance of differential splicing |
Q40463736 | Functional analysis of the inhibitor of apoptosis (iap) gene carried by the entomopoxvirus of Amsacta moorei. |
Q53592315 | Functional and genomic changes induced by alveolar transmigration in human neutrophils. |
Q40367140 | Gene profiling study of G3139- and Bcl-2-targeting siRNAs identifies a unique G3139 molecular signature |
Q40052770 | Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis |
Q24810149 | High level expression of apoptosis inhibitor in hepatoma cell line expressing Hepatitis B virus |
Q60910119 | Human antigen R mediated post-transcriptional regulation of inhibitors of apoptosis proteins in pancreatic cancer |
Q24300707 | IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis |
Q37302745 | IAP-targeted therapies for cancer |
Q81628770 | IRES in distress: translational regulation of the inhibitor of apoptosis proteins XIAP and HIAP2 during cell stress |
Q35672175 | IRES-mediated translation of cellular messenger RNA operates in eIF2α- independent manner during stress. |
Q24633776 | Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach |
Q33739941 | Identification of novel molecular regulators of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in breast cancer cells by RNAi screening |
Q36504317 | Imiquimod-induced apoptosis of melanoma cells is mediated by ER stress-dependent Noxa induction and enhanced by NF-κB inhibition. |
Q37349513 | Immunohistochemical expression of nuclear and cytoplasmic survivin in gastrointestinal carcinoma |
Q40518998 | In vitro differentiation of rat liver derived stem cells results in sensitization to TNFalpha-mediated apoptosis. |
Q35761034 | Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas |
Q33632016 | Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins. |
Q36207331 | Induction of neuronal apoptosis inhibitory protein expression in response to androgen deprivation in prostate cancer |
Q35604905 | Inhibitor of apoptosis (IAP)-like protein lacks a baculovirus IAP repeat (BIR) domain and attenuates cell death in plant and animal systems |
Q35905166 | Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer? |
Q53622762 | Involvement of caspase-2 and caspase-9 in endoplasmic reticulum stress-induced apoptosis: a role for the IAPs. |
Q28293793 | Isoform-specific silencing of the Livin gene by RNA interference defines Livin beta as key mediator of apoptosis inhibition in HeLa cells |
Q87106599 | Lactobacillus plantarum 299v Prevents Caspase-Dependent Apoptosis In Vitro |
Q55022368 | Lambertianic Acid Sensitizes Non-Small Cell Lung Cancers to TRAIL-Induced Apoptosis via Inhibition of XIAP/NF-κB and Activation of Caspases and Death Receptor 4. |
Q39852047 | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation |
Q40513940 | Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics |
Q34960600 | MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression |
Q36499234 | Malignant gliomas: strategies to increase the effectiveness of targeted molecular treatment |
Q33923972 | Mechanisms of apoptosis in Crustacea: What conditions induce versus suppress cell death? |
Q36590130 | Modulation of cancer traits by tumor suppressor microRNAs |
Q33676987 | Molecular mechanism of inhibition of survivin transcription by the GC-rich sequence-selective DNA binding antitumor agent, hedamycin: evidence of survivin down-regulation associated with drug sensitivity |
Q35804739 | Molecular mechanism of upregulation of survivin transcription by the AT-rich DNA-binding ligand, Hoechst33342: evidence for survivin involvement in drug resistance. |
Q36817109 | Molecularly targeted therapies for malignant gliomas: advances and challenges |
Q44249656 | Neisseria gonorrhoeae delays the onset of apoptosis in polymorphonuclear leukocytes |
Q28069727 | Neuroglobin, a Factor Playing for Nerve Cell Survival |
Q24338358 | Neuronal apoptosis inhibitory protein is expressed in developing kidney and is regulated by PAX2 |
Q37222549 | Neuronal apoptosis inhibitory protein is overexpressed in patients with unfavorable prognostic factors in breast cancer |
Q28274451 | Neuronal apoptosis-inhibitory protein does not interact with Smac and requires ATP to bind caspase-9 |
Q40515218 | Neutralization of Smac/Diablo by inhibitors of apoptosis (IAPs). A caspase-independent mechanism for apoptotic inhibition |
Q36044333 | Novel Polypyridyl chelators deplete cellular zinc and destabilize the X-linked inhibitor of apoptosis protein (XIAP) prior to induction of apoptosis in human prostate and breast cancer cells. |
Q36117326 | Novel role of neuronal Ca2+ sensor-1 as a survival factor up-regulated in injured neurons. |
Q79432039 | Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma |
Q36559689 | Nucleotide composition of cellular internal ribosome entry sites defines dependence on NF45 and predicts a posttranscriptional mitotic regulon |
Q37407173 | Osthole induces lung cancer cell apoptosis through inhibition of inhibitor of apoptosis family proteins |
Q42092061 | Overexpression of IAP-2 attenuates apoptosis and protects against myocardial ischemia/reperfusion injury in transgenic mice |
Q37096773 | PERK-dependent regulation of IAP translation during ER stress |
Q28941780 | Partial cleavage of RasGAP by caspases is required for cell survival in mild stress conditions |
Q35246197 | Pathways involved in interleukin-1β-mediated murine cardiomyocyte apoptosis |
Q37051197 | Programmed cell death in cardiac myocytes: strategies to maximize post-ischemic salvage. |
Q33211038 | Proliferation, apoptosis, and survivin expression in a spectrum of melanocytic nevi |
Q37251495 | REVIEW paper: pathophysiology of myocardial reperfusion injury: the role of genetically engineered mouse models |
Q36445265 | RNA-binding protein HuR mediates cytoprotection through stimulation of XIAP translation. |
Q34700466 | Rab25 Small GTPase Mediates Secretion of Tumor Necrosis Factor Receptor Superfamily Member 11b (osteoprotegerin) Protecting Cancer Cells from Effects of TRAIL |
Q33612100 | Radioprotective effects of fucoidan on bone marrow cells: improvement of the cell survival and immunoreactivity |
Q40128877 | Rapid induction of IAP family proteins and Smac/DIABLO expression after proapoptotic stimulation with doxorubicin in RPMI 8226 multiple myeloma cells |
Q42584896 | Rb/E2F4 and Smad2/3 link survivin to TGF-beta-induced apoptosis and tumor progression |
Q33208704 | Regulating cell survival by controlling cellular energy production: novel functions for ancient signaling pathways? |
Q24297305 | Regulation of NDR protein kinase by hydrophobic motif phosphorylation mediated by the mammalian Ste20-like kinase MST3 |
Q41676862 | Relationship of the expression levels of XIAP and p53 genes in hepatocellular carcinoma and the prognosis of patients |
Q21563460 | Repeated recruitment of LTR retrotransposons as promoters by the anti-apoptotic locus NAIP during mammalian evolution |
Q37992546 | Resistance to TRAIL and how to surmount it. |
Q39781842 | Role for X-linked Inhibitor of apoptosis protein upstream of mitochondrial permeabilization |
Q37826384 | Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. |
Q30410141 | Role of positive selection in functional divergence of mammalian neuronal apoptosis inhibitor proteins during evolution |
Q36272617 | RumMAGE-D the members: structure and function of a new adaptor family of MAGE-D proteins |
Q37140171 | S-nitrosylation of XIAP compromises neuronal survival in Parkinson's disease |
Q33652526 | Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter |
Q40168320 | Significant impact of survivin on myeloma cell growth. |
Q40002468 | Silencing Livin gene expression to inhibit proliferation and enhance chemosensitivity in tumor cells |
Q21260407 | Silencing of the XAF1 gene by promoter hypermethylation in cancer cells and reactivation to TRAIL-sensitization by IFN-beta |
Q35689450 | Simultaneous induction of apoptotic and survival signaling pathways in macrophage-like THP-1 cells by Shiga toxin 1 |
Q42713862 | Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism. |
Q42968932 | Smac/DIABLO expression in human gastrointestinal carcinoma: Association with clinicopathological parameters and survivin expression |
Q44762625 | Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells |
Q37680967 | Small-molecule pan-IAP antagonists: a patent review |
Q35069365 | Splice variants of mIAP1 have an enhanced ability to inhibit apoptosis |
Q33210192 | Stable transfection of extrinsic Smac gene enhances apoptosis-inducing effects of chemotherapeutic drugs on gastric cancer cells |
Q33872390 | Strain difference in photoreceptor cell death after retinal detachment in mice. |
Q24656690 | Structures of BIR domains from human NAIP and cIAP2 |
Q35723781 | Subcellular relocalization of a trans-acting factor regulates XIAP IRES-dependent translation. |
Q36073279 | Suppression of survivin promoter activity by YM155 involves disruption of Sp1-DNA interaction in the survivin core promoter. |
Q53445170 | Survivin -31G/C promoter polymorphism and sporadic colorectal cancer. |
Q38199996 | Survivin expression correlates with nodal metastasis in T1-T2 squamous cell carcinoma of the tongue. |
Q41944319 | Survivin expression is associated with lens epithelial cell proliferation and fiber cell differentiation. |
Q52337636 | TGFβ and IGF1R signaling activate protein kinase A through differential regulation of ezrin phosphorylation in colon cancer cells. |
Q35782897 | Targeting endogenous inhibitors of apoptosis for treatment of cancer, stroke and multiple sclerosis. |
Q89470234 | Targeting inhibitors of apoptosis proteins suppresses medulloblastoma cell proliferation via G2/M phase arrest and attenuated neddylation of p21 |
Q50104142 | Thalidomide potentiates etoposide-induced apoptosis in murine neuroblastoma through suppression of NF-κB activation. |
Q40178447 | The Aedes albopictus inhibitor of apoptosis 1 gene protects vertebrate cells from bluetongue virus-induced apoptosis |
Q35029111 | The Differential Effect of Toxoplasma Gondii Infection on the Stability of BCL2-Family Members Involves Multiple Activities |
Q24322401 | The apoptosis inhibitor ARC undergoes ubiquitin-proteasomal-mediated degradation in response to death stimuli: identification of a degradation-resistant mutant |
Q90611977 | The inhibitory effects of plumbagin on the NF-қB pathway and CCL2 release in racially different triple-negative breast cancer cells |
Q56995355 | The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion |
Q36557997 | The many shapes of mitochondrial death |
Q35701310 | The molecular mechanisms of glucocorticoids-mediated neutrophil survival |
Q37012579 | The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma |
Q35902423 | The protein structures that shape caspase activity, specificity, activation and inhibition |
Q33367867 | The role of endothelial cell apoptosis in inflammatory and immune diseases |
Q38714224 | The role of molecular mimicry and other factors in the association of Human Endogenous Retroviruses and autoimmunity |
Q36302070 | The signaling and apoptotic effects of TNF-related apoptosis-inducing ligand in HIV-1 associated dementia |
Q34511055 | The transcription factor Myt3 acts as a pro-survival factor in β-cells |
Q29547575 | Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis |
Q29615497 | Translational control in stress and apoptosis |
Q39006664 | Triggering receptor expressed on myeloid cells 1 (TREM-1)-mediated Bcl-2 induction prolongs macrophage survival |
Q24804943 | Two discrete events, human T-cell leukemia virus type I Tax oncoprotein expression and a separate stress stimulus, are required for induction of apoptosis in T-cells |
Q36535498 | Up-regulation of a cellular protein at the translational level by a retrovirus |
Q40059705 | Upregulation of cIAP2 in regenerating colonocytes in ulcerative colitis. |
Q38825172 | Upregulation of nuclear transporter, Kpnβ1, contributes to accelerated cell proliferation- and cell adhesion-mediated drug resistance (CAM-DR) in diffuse large B-cell lymphoma |
Q24304221 | VIAF, a conserved inhibitor of apoptosis (IAP)-interacting factor that modulates caspase activation |
Q40463082 | Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP. |
Q37008849 | X-linked inhibitor of apoptosis protein as a therapeutic target |
Q34214918 | X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitor |
Q37024493 | XIAP effects on retinal detachment-induced photoreceptor apoptosis [corrected]. |
Q33279531 | XIAP protection of photoreceptors in animal models of retinitis pigmentosa |
Q45888829 | XIAP-mediated neuroprotection in retinal ischemia |
Q83868802 | [Liver apoptosis] |
Q35105106 | miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia |
Search more.